Allworth Financial LP Pa Vmed Inc. Transaction History

Allworth Financial LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$0.36 - $0.63 $1,512 - $2,646	4,200 Added 37.78%	15,318 $5,000
Q4 2022 Jan 13, 2023	BUY	$0.41 - $18.6 $820 - $37,200	2,000 Added 21.93%	11,118 $0
Q1 2022 Apr 22, 2022	SELL	$1.16 - $2.5 $2,847 - $6,137	-2,455 Reduced 21.21%	9,118 $12,000
Q4 2021 Jan 21, 2022	SELL	$2.46 - $8.74 $984 - $3,496	-400 Reduced 3.34%	11,573 $28,000
Q3 2021 Nov 02, 2021	BUY	$5.1 - $9.39 $10,245 - $18,864	2,009 Added 20.16%	11,973 $102,000
Q2 2021 Aug 02, 2021	BUY	$3.95 - $6.88 $19,260 - $33,546	4,876 Added 95.83%	9,964 $64,000
Q1 2021 Apr 29, 2021	BUY	$2.01 - $5.55 $8,618 - $23,798	4,288 Added 536.0%	5,088 $23,000
Q4 2020 Jan 26, 2021	BUY	$1.73 - $2.13 $1,384 - $1,704	800 New	800 $2,000
Q2 2020 Jul 24, 2020	SELL	$1.75 - $2.65 $700 - $1,060	-400 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$1.15 - $3.29 $459 - $1,316	400 New	400 $1,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.